You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博雅生物(300294.SZ):擬參與設立華潤醫藥產業投資基金二期

格隆匯7月17日丨博雅生物(300294.SZ)公佈,爲落實華潤博雅生物製藥集團股份有限公司發展戰略,有效控制創新項目前期風險,儲備優質戰略項目資源,提升公司中長期持續發展與盈利能力,公司於2025年7月17日召開第八屆董事會第十四次會議、第八屆監事會第十一次會議,審議通過了《關於參與設立華潤醫藥產業投資基金二期暨關聯交易的議案》,公司擬與普通合夥人華潤醫藥(成都)企業管理合夥企業(有限合夥)(暫定名,以工商覈準名爲準)及華潤醫藥投資有限公司等10家有限合夥人共同設立華潤醫藥(成都)創新投資基金合夥企業(有限合夥)(暫定名,以工商覈準名爲準,簡稱本基金或該基金)。該基金規模爲10億元人民幣,深圳市華潤資本股權投資有限公司爲該基金管理人。公司擬作爲有限合夥人,以自有資金認繳出資總額6,000萬元人民幣,持有該基金6%的財產份額,以其認繳出資額爲限承擔有限責任。本次合夥協議尚未完成簽署,協議內容和具體操作方式以各方最終簽署的正式協議爲準。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account